Profil bibliographique

Supitcha Kamolratakul

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

5Publications signalées

10Citations signalées

1Affiliations récentes

Les institutions déclarées

Les domaines associés

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesImmune responses and vaccinationsInfluenza Virus Research StudiesVirus-based gene therapy research

Les publications récentes

Accès ouvert 2025 preprint OpenAlex

Immune Responses to a Heterologous Booster with Mrna Based Covid-19 Vaccine after Priming with an Inactivated Newcastle Disease Virus Recombinant Vaccine Expressing the Sars-Cov-2 Spike Protein (Ndv-Hxp-S)

Viravarn Luvira, Saranath Lawpoolsri Niyom, Weerapong Phumratanaprapin, Anan Jongkaewwattana et autres

th, Nigéria, us (code pays fourni par la source)

0 citations SSRN Electronic Journal

Accès ouvert 2025 preprint OpenAlex

Immune Responses of Adults Previously Received Two Doses of Inactivated Covid-19 Vaccines, and Third Dose of Any Covid-19 Vaccine Boosted with Bivalent Mrna Ancestral/Omicron Ba.4/5 Vaccine

Sant Muangnoicharoen, Saranath Lawpoolsri Niyom, Juthaporn Cowan, Viravarn Luvira et autres

th, Nigéria (code pays fourni par la source)

0 citations SSRN Electronic Journal

Accès ouvert 2024 preprint OpenAlex

Heterologous Ad26.Cov2.S Booster after Primary Bbibp-Corv Vaccination Against Sars-Cov-2 Infection: 1-Year Follow-Up of a Phase 1/2 Open-Label Trialheterologous Ad26.Cov2.S Booster after Primary Bbibp-Corv Vaccination Against Sars-Cov-2 Infection: 1-Year Follow-Up of a Phase 1/2 Open-Label Trial

Sant Muangnoicharoen, Rakpong Wiangcharoen, Saranath Lawpoolsri, Sira Nanthapisal et autres

th, Nigéria, kr, be, cn, ca (code pays fourni par la source)

0 citations SSRN Electronic Journal

Accès ouvert 2023 article OpenAlex

Single Ad26.COV2.S booster dose following two doses of BBIBP-CorV vaccine against SARS-CoV-2 infection in adults: Day 28 results of a phase 1/2 open-label trial

Sant Muangnoicharoen, Rakpong Wiangcharoen, Sira Nanthapisal, Supitcha Kamolratakul et autres

BACKGROUND: The inactivated COVID-19 whole-virus vaccine BBIBP-CorV has been extensively used worldwide. Heterologous boosting after primary vaccination can induce higher immune responses against SARS-CoV-2 than homologous boosting. The safety and immunogenicity after 28 days of a single Ad26.COV2.S booster dose given at …

th, kr, be, ca, sg (code pays fourni par la source)

9 citations Vaccine

Accès ouvert 2023 preprint OpenAlex

Single Ad26.COV2.S Booster Dose Following Two Doses of BBIBP-CorV Vaccine Against SARS-CoV-2 Infection in Adults: Day 28 Results of a Phase 1/2 Open-Label Trial

Sant Muangnoicharoen, Rakpong Wiangcharoen, Sira Nanthapisal, Supitcha Kamolratakul et autres

th, Nigéria, kr, be, cn, sg, ca (code pays fourni par la source)

1 citation SSRN Electronic Journal

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.